Finoriq research workspace
ARDELYX, INC. (ARDX) SEC Filings & Filing Highlights
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in. Review ARDX SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
- Company
- ARDELYX, INC. (ARDX)
- Ticker
- ARDX
- Market Cap
- $1.3B
- Latest Price
- $5.14
- Industry
- Biotech & Pharma
ARDELYX, INC. (ARDX) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for ARDELYX, INC. (ARDX).
| Event | Form | Date |
|---|---|---|
| Debt or FinancingDebt or Financing | 8-K2.03 | 2026-07-02 |
| On June 16, 2026, the Company held its 2026 Annual Meeting virtually. Only stockholders of reco...On June 16, 2026, the Company held its 2026 Annual Meeting virtually. Only stockholders of record at the close of business on April 22, 202... | 8-K5.07 | 2026-06-17 |
| Approval of the Second Amendment to the Amended and Restated 2014 Equity Incentive Award Plan O...Approval of the Second Amendment to the Amended and Restated 2014 Equity Incentive Award Plan On April 16, 2026, the Board of Directors (th... | 8-K5.02 | 2026-06-17 |
| Ardelyx Reports First Quarter 2026 Financial Results and Provides Business UpdateArdelyx Reports First Quarter 2026 Financial Results and Provides Business Update | 8-K7.01 | 2026-04-30 |
| Ardelyx Reports First Quarter 2026 Financial Results and Provides Business UpdateArdelyx Reports First Quarter 2026 Financial Results and Provides Business Update | 8-K2.02 | 2026-04-30 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.